Valuation: INVO Fertility, Inc.

Market Cap 1.79M 1.57M 1.46M 1.34M 2.52M 172M 2.56M 17.35M 6.77M 84.53M 6.7M 6.56M 293M P/E 2026 *
-0.04x
P/E 2027 * -0.13x
Enterprise Value 1.79M 1.57M 1.46M 1.34M 2.52M 172M 2.56M 17.35M 6.77M 84.53M 6.7M 6.56M 293M EV / Sales 2026 *
0.17x
EV / Sales 2027 * 0.11x
Free-Float
98.73%
Yield 2026 *
-
Yield 2027 * -
1 day-1.96%
1 week-3.85%
Current month-47.37%
1 month-24.24%
3 months-53.27%
6 months-87.73%
Current year-73.43%
1 week 1
Extreme 1
1.11
1 month 1
Extreme 1
3.11
Current year 1
Extreme 1
22.9
1 year 1
Extreme 1
90.8
3 years 1
Extreme 1
1,785.46
5 years 1
Extreme 1
1,785.46
10 years 1
Extreme 1
1,785.46
Date Insider Type Main position Quantity % Market Cap.
12/30/25 Other

Chief Financial Officer

4,399 0.2326%
12/3/25 Sell

Director

7 0.0004%
8/26/25 Other

Director

45,000 4.8477%
Change 5-day change 1-year change 3-year change Capi.($)
-1.96%-3.85%-98.86% - 1.79M
+2.29%+2.36%-17.97%-10.09% 180B
+1.46%+0.01%-9.87%-6.25% 107B
+1.58%+0.65%+6.69%+61.86% 60.29B
-1.13%-2.60%+26.37%+54.76% 50.19B
+2.22%-1.14%-14.85%-44.15% 43.08B
+2.98%-2.61% - - 32.77B
+1.50%-6.67%-17.52%-43.99% 27.61B
-7.67%-8.39%+17.59%-12.73% 23.1B
+1.63%-1.73%-5.80%-7.80% 20.86B
Average +0.29%-2.40%-12.69%-1.05% 54.39B
Weighted average by Cap. +1.28%-0.40%-6.63%+0.84%

Financials

2026 *2027 *
Net sales 10.42M 9.17M 8.52M 7.82M 14.68M 1.01B 14.93M 101M 39.51M 493M 39.11M 38.27M 1.71B 16.46M 14.48M 13.46M 12.36M 23.2M 1.59B 23.59M 160M 62.43M 779M 61.79M 60.46M 2.7B
Net income -5.44M -4.79M -4.45M -4.09M -7.67M -526M -7.8M -52.86M -20.64M -258M -20.43M -19.99M -892M -3.03M -2.66M -2.47M -2.27M -4.26M -292M -4.34M -29.39M -11.48M -143M -11.36M -11.11M -496M
Net Debt - -
Logo INVO Fertility, Inc.
INVO Fertility Inc. is a healthcare services fertility company, which is engaged in expanding access to assisted reproductive technology (ART) care to patients in need. The Company’s principal commercial strategy is focused on building, acquiring, and operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, profitable in vitro fertilization (IVF) clinics. The Company has four operational fertility clinics in the United States. The Company is also engaged in the sale and distribution of INVOcell to third-party owned and operated fertility clinics. INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a more connected, intimate, and affordable experience in comparison to other ART treatments.
Employees
41
Date Price Change Volume
26-07-24 US$1.000 -1.96% 128,252
26-07-23 US$1.020 -1.92% 54,516
26-07-22 US$1.040 0.00% 51,783
26-07-21 US$1.040 0.00% 64,658
26-07-20 US$1.040 0.00% 188,773
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
1.000USD
Average target price
20.00USD
Spread / Average Target
+1,900.00%

Quarterly revenue - Rate of surprise